Pertussis Completed Phase 4 Trials for Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)

Also known as: Whooping cough due to Bordetella pertussis / Whooping Cough / Whooping cough due to bordetella pertussis (B. pertussis)

IndicationStatusPhase
DBCOND0014696 (Pertussis)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02526394Pertussis and Meningitis C Concomitant Vaccination in AdolescentsTreatment
NCT01439165Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DosePrevention
NCT00319553Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®Prevention
NCT00457249A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and OlderPrevention
NCT01629589Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsPrevention
NCT01659996Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgePrevention